Trends in multidrug-resistant tuberculosis
M. F. Dias-Baptista, I.; M. R. S. Usó, S.; Marcondes-Machado, J..
J. Venom. Anim. Toxins incl. Trop. Dis.;
14(2)2008.
Artigo
em Inglês
| VETINDEX
| ID: vti-443202
Resumo
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem. The extent and burden of MDR-TB varies significantly from country to country and region to region. Globally, about three per cent of all newly diagnosed patients have MDR-TB and the proportion is higher in patients who had previously received anti-tuberculosis (anti-TB) treatment reflecting the failure of programs designed to ensure complete cure of patients with tuberculosis. The management of MDR-TB is a challenge that should be undertaken by experienced clinicians at centers equipped with reliable laboratory services and implementation of DOTS-Plus strategy.
Biblioteca responsável:
BR68.1
Texto completo